Genetic polymorphisms associated with oxaliplatin-induced peripheral neurotoxicity in Japanese patients with colorectal cancer

International Journal of Clinical Pharmacology and Therapeutics

Volumn 51, Issue 6, 2013, Pages 475-481

  Oguri, Tomoyo ^a,b   Mitsuma, Ayako ^b   Inada Inoue, Megumi ^b   Morita, Sachi ^b   Shibata, Takashi ^b   Shimokata, Tomoya ^b   Sugishita, Mihoko ^b   Nakayama, Goro ^a   Uehara, Keisuke ^a   Hasegawa, Yoshinori ^a   Ando, Yuichi ^b  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

ERCC1; Genetic polymorphism; Oxaliplatin induced chronic neurotoxicity

Indexed keywords

OXALIPLATIN;

ACYP2 GENE; ADULT; AGED; ARTICLE; BTG4 GENE; CANCER PATIENT; COLORECTAL CANCER; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DLEU7 GENE; DRUG INDUCED DISEASE; ETHNIC GROUP; FARS2 GENE; FEMALE; FOXC1 GENE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; JAPANESE; KOREAN; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; OXALIPLATIN INDUCED PERIPHERAL NEUROTOXICITY; PHARMACOGENETICS; PHARMACOGENOMICS; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; TAC1 GENE; TGA1 GENE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASIAN CONTINENTAL ANCESTRY GROUP; COLORECTAL NEOPLASMS; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; PERIPHERAL NERVOUS SYSTEM DISEASES; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84878771034     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CP201851     Document Type: Article

References (13)

1. Argyriou AA, Polychronopoulos P, Iconomou G, Chroni E, Kalofonos HP. A review on oxaliplatin-induced peripheral nerve damage. Cancer Treat Rev. 2008; 34: 368-377. CrossRef PubMed
2. Rabik CA, Dolan ME. Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev. 2007; 33: 9-23. CrossRef PubMed (Pubitemid 46137553)
3. Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neuropathy. J Neurol. 2002; 249: 9-17. CrossRef PubMed (Pubitemid 34119018)
4. Inada M, Sato M, Morita S, Kitagawa K, Kawada K, Mitsuma A, Sawaki M, Fujita K, Ando Y. Associations between oxaliplatin-induced peripheral neuropathy and polymorphisms of the ERCC1 and GSTP1 genes. Int J Clin Pharmacol Ther. 2010; 48: 729-734. PubMed
5. Krivak TC, Darcy KM, Tian C, Bookman M, Gallion H, Ambrosone CB, Deloia JA. Single nucleotide polymorphisms in ERCC1 are associated with disease progression, and survival in patients with advanced stage ovarian and primary peritoneal carcinoma; a Gynecologic Oncology Group study. Gynecol Oncol. 2011; 122: 121-126. CrossRef PubMed
6. Hong J, Han SW, Ham HS, Kim TY, Choi IS, Kim BS, Oh DY, Im SA, Kang GH, Bang YJ, Kim TY. Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis. Cancer Chemother Pharmacol. 2011; 67: 1323-1331. CrossRef PubMed
7. Cavaletti G, Alberti P, Marmiroli P. Chemotherapy- induced peripheral neurotoxicity in the era of pharmacogenomics. Lancet Oncol. 2011; 12: 1151-1161. CrossRef PubMed
8. Won HH, Lee J, Park JO, Park YS, Lim HY, Kang WK, Kim JW, Lee SY, Park SH. Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients. Cancer. 2012; 118: 2828-2836. CrossRef PubMed
9. Klipcan L, Levin I, Kessler N, Moor N, Finarov I, Safro M. The tRNA-induced conformational activation of human mitochondrial phenylalanyltRNA synthetase. Structure. 2008; 16: 1095-1104. CrossRef PubMed (Pubitemid 351899290)
10. Pennefather JN, Lecci A, Candenas ML, Patak E, Pinto FM, Maggi CA. Tachykinins and tachykinin receptors: a growing family. Life Sci. 2004; 74: 1445-1463. CrossRef PubMed (Pubitemid 38077208)
11. Ramanathan RK, Rothenberg ML, de Gramont A, Tournigand C, Goldberg RM, Gupta S, André T. Incidence and evolution of oxaliplatin-induced peripheral sensory neuropathy in diabetic patients with colorectal cancer: a pooled analysis of three phase III studies. Ann Oncol. 2010; 21: 754-758. CrossRef PubMed
12. Benavides M, Pericay C, Valladares-Ayerbes M, Gil-Calle S, Massutí B, Aparicio J, Dueñas R, González-Flores E, Carrato A, Marcuello E, Gómez A, Cabrera E, Queralt B, Gómez MJ, Guasch I, Etxeberría A, Alfaro J, Campos JM, Reina JJ, Aranda E. Oxaliplatin in combination with infusional 5-fluorouracil as first-line chemotherapy for elderly patients with metastatic colorectal cancer: a phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumors. Clin Colorectal Cancer. 2012; 11: 200-206. CrossRef PubMed
13. Cleeland CS, Farrar JT, Hausheer FH. Assessment of cancer-related neuropathy and neuropathic pain. Oncologist. 2010; 15 (Suppl 2): 13-18. CrossRef PubMed